CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit
TRAFFIC ALERT: EB I-96 CLOSED AT KENT LAKE ROAD DUE TO ACCIDENT -- MORE

New Drugs

anthrax-drug-target-lead-2012-05-08

UM Researchers Identify Potential Target For Anthrax Drug

Researchers at the University of Michigan have identified new targets for drugs that could potentially treat anthrax, the deadly infection caused by Bacillus anthracis.

WWJ Newsradio 950–05/08/2012

Synthetics Biologics

Adeona Becomes Synthetic Biologics, Inc.

Ann Arbor-based Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had received shareholder approval to change its corporate name to Synthetic Biologics Inc.

WWJ Newsradio 950–02/16/2012

adeona2

Adeona Names New Managers, Eyes Name Change

Adeona Pharmaceuticals Inc. has swapped bosses as it continues testing new drugs for multiple sclerosis, fibromyalgia and Lou Gehrig’s disease. It’s also considering a new business focus and a name change.

WWJ Newsradio 950–02/06/2012

The Van Andel Institute's Grand Rapids headquarters. Wikimedia Commons Photo.

Van Andel Study Offers New Details Of Fundamental Cell Process

A recent Van Andel Research Institute study published in the journal Science investigating the molecular structure and function of an essential plant hormone could profoundly change our understanding of a key cell process, and might ultimately lead to the development of new drugs for a variety of diseases.

WWJ Newsradio 950–01/23/2012

lycera

Lycera Achieves First Milestone in Merck Research Collaboration

Lycera Corp., a biopharmaceutical company creating innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has reached the first milestone under its research collaboration with Merck, triggering a milestone payment.

WWJ Newsradio 950–12/21/2011

A presentation at the Fifth Annual Emerging Biosciences Showcase, part of the MichBio Expo

New Blockbuster Drugs Pitched At MichBio Expo

Drugs that could bring health to tens of thousands of kidney patients, cure osteoporosis and advance the battle against cancer were featured Wednesday on the second day of MichBio Expo, the annual meeting of the state’s biosciences business community.

WWJ Newsradio 950–11/02/2011

iStockphoto

MSU, Van Andel Investigate Drug To Halt Parkinson’s Progression

Researchers from Michigan State University’s College of Human Medicine, Van Andel Research Institute and the Translational Genomics Research Institute are investigating a drug that has the potential to not only alleviate Parkinson’s symptoms but also halt the disease’s progression.

WWJ Newsradio 950–08/14/2011

lycera

Lycera Graduates from Incubator to North Campus Research Complex

Lycera, a biopharmaceutical company and University of Michigan spinoff, plans to partner and collaborate with U-M faculty and students with a move to UM’s North Campus Research Complex.

WWJ Newsradio 950–06/09/2011